Kamine Development Corporation's (KDC) has a history and mission to invest in technologies and individuals who focus on enriching and enhancing the world around us.
For over 30 years, KDC has been at the forefront of the renewable energy and telecom sectors. To date KDC have financed, owned and operated over $3.5 billion in infrastructure across the nation, partnering with numerous Fortune 100 companies along the way.
KDC Ag was created as a newly formed division of KDC to further our company’s support of sustainable and environmentally progressive technologies.
Over the past five years, KDC Ag's team has specifically sought out new technologies that could help combat the massive inefficiencies in our agriculture system including; food waste, reliance upon corn and soy for animal feed, water shortages and toxic fertilizer that currently plague our planet.
With KDC Ag's support, our partners at California Safe Soil (CSS) have now developed a revolutionary new, patented technology to significantly combat all of these issues in a scalable, and cost effective way.
KDC's entrepreneurial vision and industry experience in building national infrastructure combined with CSS's technology is the perfect remedy to help mitigate fresh food leftovers and turn it into a valuable input to create more organic and sustainable produce and animals.
KDC Ag is now scaling this technology nationwide and has created a team of industry experts poised to change the agriculture world.
Parent Company & Partners
Kamine Development Corporation
KDC Ag Parent Company - Co-founders
Hal Kamine, Matthew Kamine, Justin Kamine - Cofounder and Partners
Kamine Development Company is a family driven entrepreneurial focused development team. Since 1985 KDC has developed, built, and owned seven unregulated non-utility power generation projects located in New York and New Jersey totaling 600 megawatts and represented a capital investment of more than $800 million. KDC's partners included GE, Deutsche Bank and Siemens
Since KDC was deeply involved in the deregulation of the electric as well as the natural gas industries, they foresaw the deregulation of the telecommunications industry. With that in mind, KDC formed KMC Telecom in 1995 which eventually deployed over $2 billion in capital, had over 1,500 employees and revenues of approximately $600 million per year. KMC Telecom became one of the country's largest independent CLECs prior to its sale in 2005 and partnered with Lucent, Princeton University and GE.
In 2009, KDC also saw the initiation of the solar market across the U.S. and started KDC Solar which received a $225 million equity commitment to develop large scale net-metered solar projects. To date, KDC Solar has approximately 75 megawatts of solar operational. Learn More
Chief Financial Officer
William has over 20 years of investing and operating experience. Concurrent with his role at KDC Ag, William is a Managing Partner at Navigator Partners, LLC. William was also the CFO and Director of KMC Telecom, the country's largest privately held integrated communication provider. Prior to KMC he was Managing Director at NASSAU Capital Responsible for investing $2.5 Billion of Princeton University's $10 billion fund.
Chief Operating Officer
Barry Starkman has amassed over 35 years of experience in biopharmaceutical facility design and operation and has held engineering and manufacturing leadership roles for global biopharmaceutical companies with responsibility for design, construction, and start-up of major facilities.
As a subject matter expert, Barry has lent his unique insights into the design and implementation of robust facilities and business processes leading multi-million dollar efforts worldwide for life sciences firms including Merck, Genentech and Promega. Barry has also led the design, construction, validation and license for the world’s first high-speed isolator vial filling and formulation facilities, where he continued as director of operations. After leaving Genentech he served as Vice-President of Operations at Promega, a leading manufacturer of research grade reagents for genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity. He then became President and CEO of Hemcon Technologies which developed and commercialized a unique chitosan-based hemorrhage control bandage for multiple medical applications.